FDA.reportPublic FDA data

Afluria 2025-2026 vaccine 0.5 ML Injectable Suspension

RxCUI
2718406
RxNorm name
Afluria 2025-2026 vaccine 0.5 ML Injectable Suspension
Display name
Afluria 2025-2026 vaccine 0.5 ML Injectable Suspension
Full name
Afluria 2025-2026 vaccine 0.5 ML Injectable Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125254Afluria, Afluria QuadrivalentInfluenza Vaccine351(a)Disc2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a06c4ead-c988-4b10-b832-4d7460fa358fafluria 2025-2026 vaccine 0.5 ML Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML Injectable Suspension [Afluria 2025-2026] [SBD] · Afluria 2025-2026 vaccine 0.5 ML Injectable Suspension [SY]316These highlights do not include all the information needed to use AFLURIA ® safely and effectively. See full prescribing information for AFLURIA. AFLURIA (Influenza Vaccine) Injectable Suspension, for Intramuscular Use 2025-2026 Formula Initial U.S. Approval: 200720260309